Quantcast

Latest Biomarker Stories

2014-04-09 23:25:06

Biochemical testing suggests a pair of proteins can find and monitor bladder cancer better than standard techniques. Raleigh, NC (PRWEB) April 09, 2014 A team of Egyptian biochemists say angiogenin and clusterin – two proteins vital to certain cellular processes – could make bladder cancer diagnosis more accurate and treatments more effective. Click here to read details on the study which has just been posted on the Cancer Monthly website. Researchers with the Faculty of...

2014-04-09 12:30:43

Funding to Help Laboratory Professionals Improve Delivery of Patient Testing Guidelines and Cancer Reporting NORTHFIELD, Ill., April 9, 2014 /PRNewswire-USNewswire/ -- The College of American Pathologists (CAP), the world's largest organization of board-certified pathologists, has been awarded two grants from the Centers for Disease Control and Prevention (CDC). The funding, totaling more than $1.25 million, will be used to improve the adoption of evidence-based laboratory testing...

2014-04-08 12:30:37

-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStat(TM) prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States. An initial pilot study to be launched in April will examine 300 patient samples and is...

2014-04-07 12:33:36

Investment fuels expansion of industry-leading immunosequencing research platform and diagnostic products for the treatment of cancer, autoimmune disorders, and infectious diseases SEATTLE, April 7, 2014 /PRNewswire/ -- Adaptive Biotechnologies announced today the completion of the Company's Series C financing round and the completion of a newly created Series D round with a $105 million investment from Viking Global Investors. This investment will enable the Company to expand...

2014-04-04 23:33:41

MPI’s Drug Response Predictor (DRP) can generate new and unique clinically relevant gene signatures - a strong complementary drug development tool; TD2 is an oncology drug development company that customizes clinical trial design and execution for its customers by applying rigorous and high-throughput translational preclinical development, with best in class regulatory and clinical expertise. Scottsdale, Ariz., USA and Hoersholm, Denmark (PRWEB) April 03, 2014 Medical Prognosis...

2014-04-03 11:16:23

A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers. The findings, which were published this week online ahead of print by the journal Cancer, focus on a protein...

2014-04-02 23:26:35

RnRMarketResearch.com adds “Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) Instruments, Reagents & Services – Global Forecast to 2018” to its store. The Proteomics Market will grow from an estimated $10,223.0 million in 2013 to $20,696.4 Million by 2018. Dallas, Texas (PRWEB) April 02, 2014 The proteomics market showcases a high-growth potential, owing to the...

2014-04-01 23:27:42

Rajal B. Shah, MD, Director of Urologic Pathology for Miraca Life Sciences, presents a recent study on PTEN and ERG Biomarker Interpretation. Irving, Texas (PRWEB) April 01, 2014 Miraca Life Sciences, the nation’s largest independent anatomical pathology laboratory, is honored to present an abstract at the 2014 Meeting of the American Urological Association (AUA) May 16-21 in Orlando, Florida. Among other results, the study showed that both PTEN and ERG biomarkers demonstrate...

2014-03-31 08:30:19

DALLAS, March 31, 2014 /PRNewswire/ -- According to a new market research report "Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) Instruments, Reagents & Services - Global Forecast to 2018", published by MarketsandMarkets, The market was valued at $10,223.0 Million in 2013 and is expected to grow at a healthy CAGR from 2013 to 2018. Browse 138...

2014-03-31 08:29:21

Submission follows positive data from U.S. pivotal study CASTLE ROCK, Colo., March 31, 2014 /PRNewswire/-- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis(TM) has requested concurrent...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related